Skip to content Skip to sidebar Skip to footer

Healthcare Stocks

Here are 5 Monkeypox stocks to consider as the fight against the epidemic continues

Monkeypox stocks have enjoyed a good run in the last few weeks, with the World Health Organisation (WHO) classifying Monkeypox as a 'public health emergency of international concern'. Moneykpox is a virus that is spread through direct contact with infected liasons, bodily fluids or contaminated materials like bedding. It causes flu-like symptoms and skin blisters across…

ByNick SundichAugust 26, 2024

Here are 6 important milestones of ASX biotech companies other than clinical trial results and regulatory approval

The list of major milestones of ASX biotech companies is headed with clinical trial results, regulatory approval and commercialisation. However, clinical trials can take a long time, and there are no guarantees of success. And, as goes without saying, there won't be regulatory approval or commercialisation without results. As important as they are, there are other…

ByNick SundichAugust 23, 2024

Recce Pharmaceuticals investors are excited despite the market volatility – and there’s good reason

Recce Pharmaceuticals investors are amongst the few investors in ASX stocks that have a reason to smile right now. Their company has significantly outperformed the broader ASX, sitting in positive territory while the rest of the market has been volatile. Although there weren't any announcements out of Recce - other than the completion of its Share…

ByNick SundichAugust 22, 2024

Here are 4 economic indicators that impact stocks and investors must pay attention to

There are several economic indicators that impact stocks, both on the ASX and internationally. Whenever data is released, it can swing market indices in a particular direction, sometimes the opposite direction to where it had been heading earlier in the day. This is not only if the data changes from one period to another, but…

ByNick SundichAugust 19, 2024

As lower interest rates loom, here are 6 ASX stocks that will benefit from forthcoming rate cuts

Here 6 ASX stocks that will benefit from lower interest rates! AGL Energy (ASX:AGL) You might think AGL is on this list because people will have an easier time paying their electricity bills. Not quite for two reasons: First, Blind Freddy could tell you that, and Second, people are still paying their bills. We were…

ByNick SundichAugust 14, 2024

Curvebeam AI (ASX:CVB): Could this company be the next Pro Medicus?

Not many ASX medtech companies can boast of a then US President elect as a patient, but Curvebeam AI (ASX:CVB) is one of them. And there's good reason too - because its technology can detect injuries and fracture risk where its peers cannot. CurveBeam AI and the secret sauce behind its technology CurveBeam AI develops and…

ByNick SundichAugust 13, 2024

Here’s why investors fear a US recession, and whether the fears are justified

Investors fear a US recession - there's no denying it and there's no other explanation for the market correction in the last week. But are these fears justified? Why investors fear a US recession Because there are data points that are showing markets could be headed that way. There was a very fine tightrope central banks…

ByNick SundichAugust 6, 2024

These ASX biotechs are working with the US Department of Defence to bring new drugs to market and have a bright future ahead

Think of ASX stocks working with the US Department of Defence, and investors might imagine defence stocks or perhaps even critical mineral project developers. This is not completely untrue. The list of stocks working with the US Department of Defence includes critical mineral companies such as Lynas (ASX:LYC), which was granted US$258m back in March 2024…

ByNick SundichJuly 30, 2024

Here’s why drug reimbursement is so important for ASX healthcare stocks

Let's take a look at the concept of drug reimbursement, something that is crucial for ASX healthcare stocks looking to sell their drugs or devices, especially in the USA. So the next time you see an announcement that an ASX-listed company has had their drug or device approved for reimbursement, you should wonder why a…

ByNick SundichJuly 25, 2024

Here’s how government funding for biotechs is immensely helpful for companies and their investors

Government funding for biotechs boosts the entire sector and the players in it - including ASX-listed companies. Many investors in listed biotechs may only see capital raisings as meaningful sources of funding. Even though the money allows for companies' endeavours to become possible, capital raisings have the negative connotation of diluting shareholders and may even…

ByNick SundichJuly 4, 2024

the Kick-ass Multipurpose WordPress Theme

Healthcare Stocks

Here are 5 Monkeypox stocks to consider as the fight against the epidemic continues

Here are 6 important milestones of ASX biotech companies other than clinical trial results and regulatory approval

Recce Pharmaceuticals investors are excited despite the market volatility – and there’s good reason

Here are 4 economic indicators that impact stocks and investors must pay attention to

As lower interest rates loom, here are 6 ASX stocks that will benefit from forthcoming rate cuts

Curvebeam AI (ASX:CVB): Could this company be the next Pro Medicus?

Here’s why investors fear a US recession, and whether the fears are justified

These ASX biotechs are working with the US Department of Defence to bring new drugs to market and have a bright future ahead

Here’s why drug reimbursement is so important for ASX healthcare stocks

Here’s how government funding for biotechs is immensely helpful for companies and their investors

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Healthcare Stocks

Add Your Heading Text Here